The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cancer Biological Therapy-Global Market Insights and Sales Trends 2025
Synopsis
Cancer biological therapy is a type of treatment that uses the body's immune system to kill cancer cells. Cancer biological therapy can treat many types of cancer. It can prevent or slow tumor growth and prevent the spread of cancer. When cancer spreads, it's called metastatic cancer.
The global Cancer Biological Therapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cancer Biological Therapy in various end use industries. The expanding demands from the Hospitals, Diagnostic Laboratories, Research & Academic Laboratories and Pharmaceutical & Biotechnology Companies, are propelling Cancer Biological Therapy market. Monoclonal Antibodies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Vaccines segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Cancer Biological Therapy market, driven by demand from China, the second largest economy with some signs of stabilising, the Cancer Biological Therapy market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cancer Biological Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cancer Biological Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cancer Biological Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cancer Biological Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cancer Biological Therapy covered in this report include ELI Lilly, Sanofi, Merck, Bayer, Roche, Novartis International, Pfizer, Bristol-Myers Squibb and Seattle Genetics, etc.
The global Cancer Biological Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
ELI Lilly
Sanofi
Merck
Bayer
Roche
Novartis International
Pfizer
Bristol-Myers Squibb
Seattle Genetics
Amgen
Takeda Pharmaceuticals
GlaxoSmithKline
Spectrum Pharmaceuticals
Celgene Corporation
AstraZeneca, Plc.
Otsuka
Eisai
Abbvie
Incyte
Global Cancer Biological Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cancer Biological Therapy market, Segment by Type:
Monoclonal Antibodies
Vaccines
Cancer Growth Blockers
Blood Cell Growth Factors
Global Cancer Biological Therapy market, by Application
Hospitals
Diagnostic Laboratories
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cancer Biological Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Cancer biological therapy is a type of treatment that uses the body's immune system to kill cancer cells. Cancer biological therapy can treat many types of cancer. It can prevent or slow tumor growth and prevent the spread of cancer. When cancer spreads, it's called metastatic cancer.
The global Cancer Biological Therapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cancer Biological Therapy in various end use industries. The expanding demands from the Hospitals, Diagnostic Laboratories, Research & Academic Laboratories and Pharmaceutical & Biotechnology Companies, are propelling Cancer Biological Therapy market. Monoclonal Antibodies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Vaccines segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Cancer Biological Therapy market, driven by demand from China, the second largest economy with some signs of stabilising, the Cancer Biological Therapy market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cancer Biological Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cancer Biological Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cancer Biological Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cancer Biological Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cancer Biological Therapy covered in this report include ELI Lilly, Sanofi, Merck, Bayer, Roche, Novartis International, Pfizer, Bristol-Myers Squibb and Seattle Genetics, etc.
The global Cancer Biological Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
ELI Lilly
Sanofi
Merck
Bayer
Roche
Novartis International
Pfizer
Bristol-Myers Squibb
Seattle Genetics
Amgen
Takeda Pharmaceuticals
GlaxoSmithKline
Spectrum Pharmaceuticals
Celgene Corporation
AstraZeneca, Plc.
Otsuka
Eisai
Abbvie
Incyte
Global Cancer Biological Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cancer Biological Therapy market, Segment by Type:
Monoclonal Antibodies
Vaccines
Cancer Growth Blockers
Blood Cell Growth Factors
Global Cancer Biological Therapy market, by Application
Hospitals
Diagnostic Laboratories
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cancer Biological Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Cancer Biological Therapy
1.1 Cancer Biological Therapy Market Overview
1.1.1 Cancer Biological Therapy Product Scope
1.1.2 Cancer Biological Therapy Market Status and Outlook
1.2 Global Cancer Biological Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cancer Biological Therapy Market Size by Region (2018-2029)
1.4 Global Cancer Biological Therapy Historic Market Size by Region (2018-2023)
1.5 Global Cancer Biological Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cancer Biological Therapy Market Size (2018-2029)
1.6.1 North America Cancer Biological Therapy Market Size (2018-2029)
1.6.2 Europe Cancer Biological Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific Cancer Biological Therapy Market Size (2018-2029)
1.6.4 Latin America Cancer Biological Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa Cancer Biological Therapy Market Size (2018-2029)
2 Cancer Biological Therapy Market by Type
2.1 Introduction
2.1.1 Monoclonal Antibodies
2.1.2 Vaccines
2.1.3 Cancer Growth Blockers
2.1.4 Blood Cell Growth Factors
2.2 Global Cancer Biological Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cancer Biological Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Cancer Biological Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cancer Biological Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cancer Biological Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cancer Biological Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cancer Biological Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cancer Biological Therapy Revenue Breakdown by Type (2018-2029)
3 Cancer Biological Therapy Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Diagnostic Laboratories
3.1.3 Research & Academic Laboratories
3.1.4 Pharmaceutical & Biotechnology Companies
3.2 Global Cancer Biological Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cancer Biological Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Cancer Biological Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cancer Biological Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cancer Biological Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cancer Biological Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cancer Biological Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cancer Biological Therapy Revenue Breakdown by Application (2018-2029)
4 Cancer Biological Therapy Competition Analysis by Players
4.1 Global Cancer Biological Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Biological Therapy as of 2022)
4.3 Date of Key Players Enter into Cancer Biological Therapy Market
4.4 Global Top Players Cancer Biological Therapy Headquarters and Area Served
4.5 Key Players Cancer Biological Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Cancer Biological Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 ELI Lilly
5.1.1 ELI Lilly Profile
5.1.2 ELI Lilly Main Business
5.1.3 ELI Lilly Cancer Biological Therapy Products, Services and Solutions
5.1.4 ELI Lilly Cancer Biological Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 ELI Lilly Recent Developments
5.2 Sanofi
5.2.1 Sanofi Profile
5.2.2 Sanofi Main Business
5.2.3 Sanofi Cancer Biological Therapy Products, Services and Solutions
5.2.4 Sanofi Cancer Biological Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Sanofi Recent Developments
5.3 Merck
5.3.1 Merck Profile
5.3.2 Merck Main Business
5.3.3 Merck Cancer Biological Therapy Products, Services and Solutions
5.3.4 Merck Cancer Biological Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Bayer Recent Developments
5.4 Bayer
5.4.1 Bayer Profile
5.4.2 Bayer Main Business
5.4.3 Bayer Cancer Biological Therapy Products, Services and Solutions
5.4.4 Bayer Cancer Biological Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Bayer Recent Developments
5.5 Roche
5.5.1 Roche Profile
5.5.2 Roche Main Business
5.5.3 Roche Cancer Biological Therapy Products, Services and Solutions
5.5.4 Roche Cancer Biological Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Roche Recent Developments
5.6 Novartis International
5.6.1 Novartis International Profile
5.6.2 Novartis International Main Business
5.6.3 Novartis International Cancer Biological Therapy Products, Services and Solutions
5.6.4 Novartis International Cancer Biological Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 Novartis International Recent Developments
5.7 Pfizer
5.7.1 Pfizer Profile
5.7.2 Pfizer Main Business
5.7.3 Pfizer Cancer Biological Therapy Products, Services and Solutions
5.7.4 Pfizer Cancer Biological Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 Pfizer Recent Developments
5.8 Bristol-Myers Squibb
5.8.1 Bristol-Myers Squibb Profile
5.8.2 Bristol-Myers Squibb Main Business
5.8.3 Bristol-Myers Squibb Cancer Biological Therapy Products, Services and Solutions
5.8.4 Bristol-Myers Squibb Cancer Biological Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Bristol-Myers Squibb Recent Developments
5.9 Seattle Genetics
5.9.1 Seattle Genetics Profile
5.9.2 Seattle Genetics Main Business
5.9.3 Seattle Genetics Cancer Biological Therapy Products, Services and Solutions
5.9.4 Seattle Genetics Cancer Biological Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 Seattle Genetics Recent Developments
5.10 Amgen
5.10.1 Amgen Profile
5.10.2 Amgen Main Business
5.10.3 Amgen Cancer Biological Therapy Products, Services and Solutions
5.10.4 Amgen Cancer Biological Therapy Revenue (US$ Million) & (2018-2023)
5.10.5 Amgen Recent Developments
5.11 Takeda Pharmaceuticals
5.11.1 Takeda Pharmaceuticals Profile
5.11.2 Takeda Pharmaceuticals Main Business
5.11.3 Takeda Pharmaceuticals Cancer Biological Therapy Products, Services and Solutions
5.11.4 Takeda Pharmaceuticals Cancer Biological Therapy Revenue (US$ Million) & (2018-2023)
5.11.5 Takeda Pharmaceuticals Recent Developments
5.12 GlaxoSmithKline
5.12.1 GlaxoSmithKline Profile
5.12.2 GlaxoSmithKline Main Business
5.12.3 GlaxoSmithKline Cancer Biological Therapy Products, Services and Solutions
5.12.4 GlaxoSmithKline Cancer Biological Therapy Revenue (US$ Million) & (2018-2023)
5.12.5 GlaxoSmithKline Recent Developments
5.13 Spectrum Pharmaceuticals
5.13.1 Spectrum Pharmaceuticals Profile
5.13.2 Spectrum Pharmaceuticals Main Business
5.13.3 Spectrum Pharmaceuticals Cancer Biological Therapy Products, Services and Solutions
5.13.4 Spectrum Pharmaceuticals Cancer Biological Therapy Revenue (US$ Million) & (2018-2023)
5.13.5 Spectrum Pharmaceuticals Recent Developments
5.14 Celgene Corporation
5.14.1 Celgene Corporation Profile
5.14.2 Celgene Corporation Main Business
5.14.3 Celgene Corporation Cancer Biological Therapy Products, Services and Solutions
5.14.4 Celgene Corporation Cancer Biological Therapy Revenue (US$ Million) & (2018-2023)
5.14.5 Celgene Corporation Recent Developments
5.15 AstraZeneca, Plc.
5.15.1 AstraZeneca, Plc. Profile
5.15.2 AstraZeneca, Plc. Main Business
5.15.3 AstraZeneca, Plc. Cancer Biological Therapy Products, Services and Solutions
5.15.4 AstraZeneca, Plc. Cancer Biological Therapy Revenue (US$ Million) & (2018-2023)
5.15.5 AstraZeneca, Plc. Recent Developments
5.16 Otsuka
5.16.1 Otsuka Profile
5.16.2 Otsuka Main Business
5.16.3 Otsuka Cancer Biological Therapy Products, Services and Solutions
5.16.4 Otsuka Cancer Biological Therapy Revenue (US$ Million) & (2018-2023)
5.16.5 Otsuka Recent Developments
5.17 Eisai
5.17.1 Eisai Profile
5.17.2 Eisai Main Business
5.17.3 Eisai Cancer Biological Therapy Products, Services and Solutions
5.17.4 Eisai Cancer Biological Therapy Revenue (US$ Million) & (2018-2023)
5.17.5 Eisai Recent Developments
5.18 Abbvie
5.18.1 Abbvie Profile
5.18.2 Abbvie Main Business
5.18.3 Abbvie Cancer Biological Therapy Products, Services and Solutions
5.18.4 Abbvie Cancer Biological Therapy Revenue (US$ Million) & (2018-2023)
5.18.5 Abbvie Recent Developments
5.19 Incyte
5.19.1 Incyte Profile
5.19.2 Incyte Main Business
5.19.3 Incyte Cancer Biological Therapy Products, Services and Solutions
5.19.4 Incyte Cancer Biological Therapy Revenue (US$ Million) & (2018-2023)
5.19.5 Incyte Recent Developments
6 North America
6.1 North America Cancer Biological Therapy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cancer Biological Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cancer Biological Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cancer Biological Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cancer Biological Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cancer Biological Therapy Market Dynamics
11.1 Cancer Biological Therapy Industry Trends
11.2 Cancer Biological Therapy Market Drivers
11.3 Cancer Biological Therapy Market Challenges
11.4 Cancer Biological Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
